CONGENITAL DYSERYTHROPOIETIC ANEMIA

 

CONGENITAL DYSERYTHROPOIETIC ANEMIA

 

DEFINITION:

A group of disorders characterized by a congenital defect in erythropoiesis and reticulocytosis resulting in erythroblast multinuclearity and anemia.

EPIDEMIOLOGY:

  • incidence: ? (210 cases reported)
  • age of onset:
    • infancy to adulthood
    • mean age: 15 years (Types I and II), 22 years (Type III)
  • risk factors:
    • familial - autosomal recessive (Types I and II)
      • autosomal dominant (Type III)
    • sex - Type I - M > F (1.25:1)
    • Type II - M = F
    • Type III - M > F (1.9:1)

PATHOGENESIS:

1. Background

  • considered to be one of at least 3 disorders where there is a congenital deficiency in erythroid precursors
    • other congenital cytopenias:
      • Diamond-Blackfan Syndrome
      • AASE Syndrome

2. Genetic Defect(s)

  • genetic defect(s) -> ineffective and morphologically abnormal erythropoiesis (dyserythropoiesis) -> block at the mature erythroblast level (normal proerythroblasts with erythroid hyperplasia) but abnormal mature erythroblasts (polychromatophilic and orthochromatic erythroblasts)

PATHOLOGY (Bone Marrow):

1. Type I

  • dissociation of nuclear and cytoplasmic maturation (i.e., immature nuclear maturation)
  • immature megaloblastoid nuclei
  • binucleated
  • internuclear chromatin bridges

2. Type II

  • bi- and multinucleated mature erythroblasts
  • double cytoplasmic membrane (excess rER)
  • karyorrhexis, pluripolar mitoses

3. Type III

  • multinucleated mature erythroblasts
  • gigantoblasts (up to 12 nuclei per erythroblast)

CLINICAL FEATURES:

1. Type I (15% of cases)

  • mild to moderate anemia
  • jaundice (+/- icterus), moderate splenomegaly

2. Type II (60-65% of cases)

  • mild to severe anemia
  • jaundice, hepatosplenomegaly (hepatomegaly)

3. Type III (20-25% of cases)

  • mild to moderate anemia
  • hepatosplenomegaly

4. Complications

  • gallstones (from hemolytic anemia)
  • hemosiderosis (from increased GI iron absorption due to marked erythroid hyperplasia)

INVESTIGATIONS:

1. Serum

1. Type I:

  • Hb: macrocytic (mean = 90 g/L), low reticulocytes (1-7%)
  • normal WBC and platelets
  • smear - anisocytosis, poikilocytes, punctate basophilia, helmet and tadpole cells, Cabot's rings
  • elevated bilirubin (indirect), LDH

2. Type II:

  • Hb: normocytic (mean = 65 g/L), low reticulocytes (4%)
  • smear - anisocytosis, poikilocytosis, tear drops, basophilic stippling
  • pathognomonic - Type II CDA RBC's are lysed by 30% of acidified sera from normal individuals (these RBC's have a specific HEMPAS antigen while normal sera contain an anti-HEMPAS IgM antibody)
  • presence of fetal membrane antigen i

3. Type III:

  • Hb: macrocytic (mean = 80 g/L), low reticulocytes (2-4%)
  • smear - anisocytosis, poikilocytosis, basophilic stippling

2. Bone Marrow

  • see "Pathology"

MANAGEMENT:

1. Supportive

  • PRBC transfusions, splenectomy (Type II)

2. Hemosiderosis

  • prophylactic phlebotomy
  • iron chelators

 

 

 

Pediatric Database - CONGENITAL DYSERYTHROPOIETIC ANEMIA

Pediatric Organization - Pedbase [at] Gmail.com